mRNA-based universal influenza vaccine (Tiba Biotech/Icahn School of Medicine at Mount Sinai)

N/A

Report date: 2025/12/12 17:32:32

Base Information

Drug NamemRNA-based universal influenza vaccine (Tiba Biotech/Icahn School of Medicine at Mount Sinai)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTiba Biotech LLC
China Registration ClassN/A

Develop Information

Active CompaniesTiba Biotech LLC
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A